Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

343 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients.
Hu-Lieskovan S, Vallbohmer D, Zhang W, Yang D, Pohl A, Labonte MJ, Grimminger PP, Hölscher AH, Semrau R, Arnold D, Dellas K, Debucquoy A, Haustermans K, Machiels JP, Sempoux C, Rödel C, Bracko M, Velenik V, Lenz HJ. Hu-Lieskovan S, et al. Among authors: haustermans k. Clin Cancer Res. 2011 Aug 1;17(15):5161-9. doi: 10.1158/1078-0432.CCR-10-2666. Epub 2011 Jun 14. Clin Cancer Res. 2011. PMID: 21673069 Free PMC article.
Molecular responses of rectal cancer to preoperative chemoradiation.
Debucquoy A, Goethals L, Geboes K, Roels S, Mc Bride WH, Haustermans K. Debucquoy A, et al. Among authors: haustermans k. Radiother Oncol. 2006 Aug;80(2):172-7. doi: 10.1016/j.radonc.2006.07.016. Epub 2006 Aug 14. Radiother Oncol. 2006. PMID: 16905208 Clinical Trial.
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.
Machiels JP, Sempoux C, Scalliet P, Coche JC, Humblet Y, Van Cutsem E, Kerger J, Canon JL, Peeters M, Aydin S, Laurent S, Kartheuser A, Coster B, Roels S, Daisne JF, Honhon B, Duck L, Kirkove C, Bonny MA, Haustermans K. Machiels JP, et al. Among authors: haustermans k. Ann Oncol. 2007 Apr;18(4):738-44. doi: 10.1093/annonc/mdl460. Epub 2007 Jan 5. Ann Oncol. 2007. PMID: 17208931 Free article. Clinical Trial.
Radiotherapy for bladder cancer.
Milosevic M, Gospodarowicz M, Zietman A, Abbas F, Haustermans K, Moonen L, Rödel C, Schoenberg M, Shipley W. Milosevic M, et al. Among authors: haustermans k. Urology. 2007 Jan;69(1 Suppl):80-92. doi: 10.1016/j.urology.2006.05.060. Urology. 2007. PMID: 17280910 Review.
Morphological features and molecular markers in rectal cancer from 95 patients included in the European Organisation for Research and Treatment of Cancer 22921 trial: prognostic value and effects of preoperative radio (chemo) therapy.
Debucquoy A, Libbrecht L, Roobrouck V, Goethals L, McBride W, Haustermans K. Debucquoy A, et al. Among authors: haustermans k. Eur J Cancer. 2008 Apr;44(6):791-7. doi: 10.1016/j.ejca.2008.02.023. Epub 2008 Mar 18. Eur J Cancer. 2008. PMID: 18353631 Free PMC article. Clinical Trial.
T-cell responses to survivin in cancer patients undergoing radiation therapy.
Schaue D, Comin-Anduix B, Ribas A, Zhang L, Goodglick L, Sayre JW, Debucquoy A, Haustermans K, McBride WH. Schaue D, et al. Among authors: haustermans k. Clin Cancer Res. 2008 Aug 1;14(15):4883-90. doi: 10.1158/1078-0432.CCR-07-4462. Clin Cancer Res. 2008. PMID: 18676762 Free PMC article.
Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer.
Debucquoy A, Haustermans K, Daemen A, Aydin S, Libbrecht L, Gevaert O, De Moor B, Tejpar S, McBride WH, Penninckx F, Scalliet P, Stroh C, Vlassak S, Sempoux C, Machiels JP. Debucquoy A, et al. Among authors: haustermans k. J Clin Oncol. 2009 Jun 10;27(17):2751-7. doi: 10.1200/JCO.2008.18.5033. Epub 2009 Mar 30. J Clin Oncol. 2009. PMID: 19332731 Clinical Trial.
343 results